Evidence map›Paper›PMID 31630358›Full record

ArticleChinese journal of integrative medicine2020

Effects of TAT-SOD at Acupoints on Essential Hypertension by Monitoring Meridians Electrical Potential.

Jing-Ke Guo, Jin-Sen Xu, Tian-Bao Chen, Ming-Ming Xu, Shu-Tao Liu, Chao-Xin Zhang, Li-Jing Ke, Jian-Wu Zhou, Qiang Wang, Ping-Fan Rao

Open access · greenAbstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Chinese journal of integrative medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Oxidative Stress, Antioxidants and Hypertension.Antioxidants (Basel, Switzerland) · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Jing-Ke GuoShanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Zhejiang Gongshang University Joint Centre for Food and Nutrition Research, Zhejiang Gongshang University, Hangzhou, 310035, China.
Jin-Sen XuAcupuncture College, Fujian University of Traditional Chinese Medicine, Fuzhou, 350003, China.
Tian-Bao ChenNatural Drug Discovery Group, School of Pharmacy, Queen's University, Belfast, BT97BL, UK.
Ming-Ming XuCollege of Oceanology and Food Science, Quanzhou Normal University, Quanzhou, Fujian, 362000, China.
Shu-Tao LiuCollege of Biological Science and Technology, Fuzhou University, Fuzhou, 350108, China.
Chao-Xin ZhangGuangzhou Halcyon Technology Ltd., Guangzhou, 510630, China.
Li-Jing KeShanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Zhejiang Gongshang University Joint Centre for Food and Nutrition Research, Zhejiang Gongshang University, Hangzhou, 310035, China.
Jian-Wu ZhouShanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Zhejiang Gongshang University Joint Centre for Food and Nutrition Research, Zhejiang Gongshang University, Hangzhou, 310035, China.
Qiang WangInstitute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing, 100193, China.
Ping-Fan RaoShanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Zhejiang Gongshang University Joint Centre for Food and Nutrition Research, Zhejiang Gongshang University, Hangzhou, 310035, China. pingfan.rao@gmail.com.
Chinese Academy of Sciences · CNShanghai Institutes for Biological Sciences · CNFujian University of Traditional Chinese Medicine · CNFuzhou University · CNInstitute of Food Science and Technology · CNQuanzhou Normal University · CNQueen's University Belfast · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the effect on essential hypertension of the topical application of TAT-Cu, Zn-superoxide dismutase (TAT-SOD) at left acupoint Zusanli (ST 36), and to observe whether the change of electrical potential difference (EPD) can be related to the change of blood pressure.

methodsSixteen patients with essential hypertension and 16 healthy subjects were included in the study. EPD between the left acupoints of Yanglingquan (GB 34) and Qiuxu (GB 40) was firstly screened out for the EPD detection. An intracellular superoxide quenching enzyme, TAT-SOD, was topically applied to the acupoint ST 36 within an area of 1 cm

resultsEPDs between the left acupoints of GB 34 and GB 40 for 16 patients of essential hypertension and 16 healthy subjects were 44.9±6.4 and 5.6±0.9 mV, respectively. Daily application of TAT-SOD for 15 days at ST 36 of essential hypertension patients significantly decreased systolic blood pressure (SBP) and diastolic blood pressure (DBP) of 179.6 and 81.5 mm Hg to 153.1 and 74.1 mm Hg, respectively. Responding to the change in blood pressure, EPD between the left acupoints of GB 34 and GB 40 also declined from 44.4 to 22.8 mV with the same trend. No change was observed with SBP, DBP and EPD between the left acupoints of GB 34 and GB 40 with the daily application of the placebo cream.

conclusionEnzymatic scavenging of the intracellular superoxide at ST 36 proved to be effective in decreasing SBP and DBP. The results reconfirm the involvement of superoxide anions and its transportation along the meridians, and demonstrate that EPD between acupoints may be an indicator to reflect its functioning status. Moreover, preliminary results suggest a close correlation between EPD and blood pressure readings, implying a possibility of using EPD as a sensitive parameter for blood pressure and to monitor the effect of antihypertensive treatment.

Indexed as

Action PotentialsMeridiansAcupuncture PointsAcupuncture TherapyAdultBlood PressureCombined Modality TherapyElectric ConductivityEssential HypertensionFemaleHumansMaleReactive Oxygen SpeciesSuperoxide DismutaseReactive Oxygen SpeciesSuperoxide Dismutaseacupointselectrical potentialessential hypertensionreactive oxygen speciesTAT-SOD

Identifiers

PMID31630358
OpenAlexW2981060196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.